3 Biotechs That Have Doubled Investors' Money in Less Than a Year Post author:Sam Post published:January 22, 2018 Post category:BioPharma Having a stock double in value is a good thing. Source: BioSpace You Might Also Like Why Gilead Could Take Out Juno But Face Major Competition From This Biotech Giant August 29, 2017 Alder Announces $250M Committed Equity Financing January 7, 2018 Gilead Quietly Starts Recruiting Employees for China Expansion April 6, 2017
